218 related articles for article (PubMed ID: 15221916)
1. Use of autologous instead of allogeneic blood transfusion during esophagectomy prolongs disease-free survival among patients with recurrent esophageal cancer.
Motoyama S; Okuyama M; Kitamura M; Saito R; Kamata S; Murata K; Ogawa J
J Surg Oncol; 2004 Jul; 87(1):26-31. PubMed ID: 15221916
[TBL] [Abstract][Full Text] [Related]
2. Survival advantage of using autologous blood transfusion during surgery for esophageal cancer.
Motoyama S; Saito R; Kamata S; Kitamura M; Okuyama M; Imano H; Nakamura M; Suzuki H; Omokawa S; Motohashi Y; Ogawa J
Surg Today; 2002; 32(11):951-8. PubMed ID: 12444430
[TBL] [Abstract][Full Text] [Related]
3. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
4. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy.
Nakagawa S; Kanda T; Kosugi S; Ohashi M; Suzuki T; Hatakeyama K
J Am Coll Surg; 2004 Feb; 198(2):205-11. PubMed ID: 14759776
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative pathological investigation of recurrent nerve nodal metastasis can guide the decision whether to perform cervical lymph node dissection in thoracic esophageal cancer.
Ueda Y; Shiozaki A; Itoi H; Okamoto K; Fujiwara H; Ichikawa D; Kikuchi S; Fuji N; Itoh T; Ochiai T; Komatsu S; Yamagishi H
Oncol Rep; 2006 Nov; 16(5):1061-6. PubMed ID: 17016593
[TBL] [Abstract][Full Text] [Related]
6. Classification of recurrent esophageal cancer after radical esophagectomy with two- or three-field lymphadenectomy.
Kato H; Fukuchi M; Miyazaki T; Nakajima M; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Manda R; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2005; 25(5):3461-7. PubMed ID: 16101164
[TBL] [Abstract][Full Text] [Related]
7. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].
Chen G; Wang Z; Liu XY; Liu FY
Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
[TBL] [Abstract][Full Text] [Related]
9. Effect of substituting allogenic blood transfusion with autologous blood transfusion on outcomes after radical oesophagectomy for cancer.
Takemura M; Osugi H; Higashino M; Takada N; Lee S; Kinoshita H
Ann Thorac Cardiovasc Surg; 2005 Oct; 11(5):293-300. PubMed ID: 16299455
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinical evaluation of axillary lymph node metastasis in esophageal cancer.
Komatsu S; Ueda Y; Ichikawa D; Fujiwara H; Okamoto K; Kikuchi S; Shiozaki A; Imura K; Ohsawa R; Ochiai T; Tsubokura T; Yamagishi H
Jpn J Clin Oncol; 2007 Apr; 37(4):314-8. PubMed ID: 17553821
[TBL] [Abstract][Full Text] [Related]
11. [Endoscopic mucosal resection for esophageal cancer].
Momma K; Yoshida M
Gan To Kagaku Ryoho; 2003 Jul; 30(7):914-9. PubMed ID: 12894703
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
[TBL] [Abstract][Full Text] [Related]
13. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
14. Survival and clinical evaluation of salvage operation for cervical lymph node recurrence in esophageal cancer.
Komatsu S; Shioaki Y; Ichikawa D; Hamashima T; Kan K; Ueshima Y; Koide K; Lee CJ; Ikeda E; Mutoh F; Kurioka H; Oka T; Yamagishi H
Hepatogastroenterology; 2005; 52(63):796-9. PubMed ID: 15966207
[TBL] [Abstract][Full Text] [Related]
15. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
[TBL] [Abstract][Full Text] [Related]
16. Total number of resected lymph nodes predicts survival in esophageal cancer.
Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M
Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
[TBL] [Abstract][Full Text] [Related]
17. A prospective trial for avoiding cervical lymph node dissection for thoracic esophageal cancers, based on intra-operative genetic diagnosis of micrometastasis in recurrent laryngeal nerve chain nodes.
Miyata H; Yano M; Doki Y; Yasuda T; Yoshioka S; Sugita Y; Takiguchi S; Fujiwara Y; Monden M
J Surg Oncol; 2006 May; 93(6):477-84. PubMed ID: 16615150
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
[TBL] [Abstract][Full Text] [Related]
19. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
20. The role of salvage surgery for recurrence of esophageal squamous cell cancer.
Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Setoyama T; Uenosono Y; Ishigami S; Owaki T; Aikou T
Eur J Surg Oncol; 2006 Jun; 32(5):544-7. PubMed ID: 16567077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
